These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 15934834)

  • 1. Yeasts encoding tumour antigens in cancer immunotherapy.
    Franzusoff A; Duke RC; King TH; Lu Y; Rodell TC
    Expert Opin Biol Ther; 2005 Apr; 5(4):565-75. PubMed ID: 15934834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA vaccines to attack cancer: Strategies for improving immunogenicity and efficacy.
    Tiptiri-Kourpeti A; Spyridopoulou K; Pappa A; Chlichlia K
    Pharmacol Ther; 2016 Sep; 165():32-49. PubMed ID: 27235391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immunotherapy of solid cancers based on cloning the genes encoding tumor-rejection antigens.
    Rosenberg SA
    Annu Rev Med; 1996; 47():481-91. PubMed ID: 8712798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [NY-ESO-1 and cancer immunotherapy].
    Peng JR; Leng XS
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Aug; 30(4):371-7. PubMed ID: 18795604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new era for cancer immunotherapy based on the genes that encode cancer antigens.
    Rosenberg SA
    Immunity; 1999 Mar; 10(3):281-7. PubMed ID: 10204484
    [No Abstract]   [Full Text] [Related]  

  • 6. Immune responses to tumour antigens: implications for antigen specific immunotherapy of cancer.
    Jäger D; Jäger E; Knuth A
    J Clin Pathol; 2001 Sep; 54(9):669-74. PubMed ID: 11533070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypermutated tumours in the era of immunotherapy: The paradigm of personalised medicine.
    Nebot-Bral L; Brandao D; Verlingue L; Rouleau E; Caron O; Despras E; El-Dakdouki Y; Champiat S; Aoufouchi S; Leary A; Marabelle A; Malka D; Chaput N; Kannouche PL
    Eur J Cancer; 2017 Oct; 84():290-303. PubMed ID: 28846956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in the development of immunotherapy for the treatment of patients with cancer.
    Rosenberg SA
    J Intern Med; 2001 Dec; 250(6):462-75. PubMed ID: 11902815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific immunotherapy of cancer in elderly patients.
    Matzku S; Zöller M
    Drugs Aging; 2001; 18(9):639-64. PubMed ID: 11599633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting neoantigens to augment antitumour immunity.
    Yarchoan M; Johnson BA; Lutz ER; Laheru DA; Jaffee EM
    Nat Rev Cancer; 2017 Apr; 17(4):209-222. PubMed ID: 28233802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor neoantigens: building a framework for personalized cancer immunotherapy.
    Gubin MM; Artyomov MN; Mardis ER; Schreiber RD
    J Clin Invest; 2015 Sep; 125(9):3413-21. PubMed ID: 26258412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy.
    Coulie PG; Van den Eynde BJ; van der Bruggen P; Boon T
    Nat Rev Cancer; 2014 Feb; 14(2):135-46. PubMed ID: 24457417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor antigen discovery through translation of the cancer genome.
    Khodadoust MS; Alizadeh AA
    Immunol Res; 2014 May; 58(2-3):292-9. PubMed ID: 24718952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunity to tumour antigens.
    Li G; Ali SA; McArdle SE; Mian S; Ahmad M; Miles A; Rees RC
    Curr Pharm Des; 2005; 11(27):3501-9. PubMed ID: 16248804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contemporary immunotherapy of solid tumors: from tumor-associated antigens to combination treatments.
    Spagnoli GC; Ebrahimi M; Iezzi G; Mengus C; Zajac P
    Curr Opin Drug Discov Devel; 2010 Mar; 13(2):184-92. PubMed ID: 20205052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical applications of recombinant virus-based cancer immunotherapy.
    Adamina M; Daetwiler S; Rosenthal R; Zajac P
    Expert Opin Biol Ther; 2005 Sep; 5(9):1211-24. PubMed ID: 16120051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer vaccines and immunotherapy.
    Dermime S; Armstrong A; Hawkins RE; Stern PL
    Br Med Bull; 2002; 62():149-62. PubMed ID: 12176857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratumoral immunotherapy: using the tumour against itself.
    Crittenden MR; Thanarajasingam U; Vile RG; Gough MJ
    Immunology; 2005 Jan; 114(1):11-22. PubMed ID: 15606790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour immunotherapy: the adjuvant treatment of the 21st century?
    Bremers AJ; Kuppen PJ; Parmiani G
    Eur J Surg Oncol; 2000 Jun; 26(4):418-24. PubMed ID: 10873365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic cells as vectors for immunotherapy of cancer.
    Paczesny S; Ueno H; Fay J; Banchereau J; Palucka AK
    Semin Cancer Biol; 2003 Dec; 13(6):439-47. PubMed ID: 15001163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.